ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 335 filers reported holding ARGENX SE in Q3 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $4,787,000 | – | 75,816 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 39,370 | $14,917,000 | 13.60% |
| Tri Locum Partners LP | 82,735 | $31,347,000 | 12.84% |
| Avoro Capital Advisors LLC | 1,265,555 | $479,493,000 | 9.48% |
| Artal Group S.A. | 400,000 | $151,552,000 | 8.10% |
| Finepoint Capital LP | 52,800 | $20,005,000 | 6.92% |
| Paradigm Biocapital Advisors LP | 88,816 | $33,651,000 | 6.71% |
| Fairmount Funds Management LLC | 73,526 | $27,858,000 | 6.38% |
| DCF Advisers, LLC | 25,000 | $9,472,000 | 5.64% |
| Redmile Group, LLC | 385,818 | $146,179,000 | 5.58% |
| Eagle Health Investments LP | 60,300 | $22,846,000 | 5.33% |